Policy / Regulatory

Beijing Adjusts UEBMI Account Management, Boosting Outpatient Coverage

Company

Junshi Biosciences’ H1 2022 Financials Show Tuoyi Sales Growth Despite Revenue Drop

CompanyDrug

Connect Biopharma Completes Phase I Trial of CBP-174 for Itch in Skin Diseases

CompanyDeals

RoosterBio Taps MBL Beijing Biotech as Exclusive Distributor in China

CompanyDrug

Boehringer, Eli Lilly’s Jardiance Wins NMPA Approval for Heart Failure with Preserved Ejection Fraction

CompanyDeals

E-nitiate Biopharma Raises RMB 100M in Series A to Advance Autoimmune Disease Drugs

CompanyDeals

Kangtai Bio Partners with Philippine Firm on Pneumonia Vaccines

Company

MicroPort Scientific Posts 10% Revenue Growth Despite COVID-19 in 2022 Interim Results

CompanyDrug

Merck’s Gardasil 9-Valent HPV Vaccine Approved for Expanded Age Range in China

CompanyDeals

Onekdrug Raises Series B+ Funding to Boost Pharmaceutical B2B Services

CompanyDrug

Sinocelltech’s Ripertamab Wins NMPA Approval for DLBCL Treatment

Company

Fosun Pharma’s H1 2022 Revenue Rises 25.9% on New Drug Launches, Global Expansion